{"id":105365,"date":"2025-10-27T08:11:56","date_gmt":"2025-10-27T13:11:56","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?p=105365"},"modified":"2025-10-27T08:41:55","modified_gmt":"2025-10-27T13:41:55","slug":"nytt-hap-innen-malrettet-behandling-av-histiocytose-2","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/nb\/new-hope-in-targeted-therapy-for-histiocytosis\/","title":{"rendered":"Nytt h\u00e5p innen m\u00e5lrettet behandling av histiocytose"},"content":{"rendered":"<div>\n<p class=\"x_MsoNormal\"><span data-olk-copy-source=\"MessageBody\">En ny studie fra\u00a0<b>Memorial Sloan Kettering kreftsykehus<\/b>\u00a0fremhever potensialet i\u00a0<b>ulixertinib<\/b>, et legemiddel for m\u00e5lrettet behandling som hemmer ERK, til behandling av visse former for\u00a0<b>histiocytose,<\/b>\u00a0blant annet <b>Erdheim-Chester-syndromet (ECD)<\/b>.<\/span><\/p>\n<p class=\"x_MsoNormal\">Denne forskningen, ledet av dr. Eli Diamond, medlem av ECDGAs medisinske r\u00e5dgivningsutvalg, markerer et spennende fremskritt i behandlingen av MAPK-relaterte histiocytiske sykdommer. For mange i v\u00e5rt fellesskap, som Joey \u2013 et medlem av ECDGA hvis historie fortsetter \u00e5 inspirere oss \u2013 representerer disse vitenskapelige gjennombruddene langt mer enn klinisk fremgang. De gir h\u00e5p.<\/p>\n<p class=\"x_MsoNormal\">Les nyhetsartikkelen fra MSKCC:<br \/>\n<a title=\"https:\/\/www.mskcc.org\/news\/targeted-therapy-drug-ulixertinib-for-histiocytosis-blood\" href=\"https:\/\/www.mskcc.org\/news\/targeted-therapy-drug-ulixertinib-for-histiocytosis-blood\" target=\"_blank\" rel=\"noopener\" data-auth=\"NotApplicable\" data-linkindex=\"2\">https:\/\/www.mskcc.org\/news\/targeted-therapy-drug-ulixertinib-for-histiocytosis-blood<\/a><\/p>\n<p class=\"x_MsoNormal\">Les hele den tekniske artikkelen i <i>Kreftcelle<\/i>:<br \/>\n<a title=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1535610825004064\" href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1535610825004064\" target=\"_blank\" rel=\"noopener\" data-auth=\"NotApplicable\" data-linkindex=\"3\">https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1535610825004064<\/a><\/p>\n<p class=\"x_MsoNormal\">Hos ECDGA er vi stolte av \u00e5 st\u00f8tte og formidle forskning som bringer oss n\u00e6rmere bedre behandling, flere svar og, en dag, en kur.<\/p>\n<p><em>Erdheim-Chester Disease Global Alliance (ECDGA) gir ikke medisinsk r\u00e5dgivning, stiller ikke diagnoser og tilbyr ikke behandling. Alt innhold er kun ment som informasjon. Ta kontakt med helsepersonell dersom du har medisinske sp\u00f8rsm\u00e5l.<\/em><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>En ny studie fra Memorial Sloan Kettering Cancer Center fremhever det lovende potensialet til ulixertinib, et m\u00e5lrettet legemiddel som hemmer ERK, for behandling av visse former for histiocytose \u2013 blant annet Erdheim-Chester-syndromet (ECD).<\/p>","protected":false},"author":14,"featured_media":105366,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[51],"tags":[375,2599,5100,5103,5107,102,5104,5105,5106,3473,5101,4254,5108,5102,4957],"class_list":["post-105365","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-ecdawareness","tag-elidiamond","tag-erdheim-chesterdisease","tag-erkinhibitor","tag-histiocyticdisorders","tag-histiocytosis","tag-mapkpathway","tag-memorialsloankettering","tag-precisionmedicine","tag-rarebloodcancer","tag-rarecancer","tag-rarediseaseresearch","tag-researchbreakthrough","tag-targetedtherapy","tag-ulixertinib"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/posts\/105365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/comments?post=105365"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/posts\/105365\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/media\/105366"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/media?parent=105365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/categories?post=105365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/tags?post=105365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}